首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

2054299

獸用皮膚病藥物市場：依藥物類型、目標動物及地區分類

Veterinary Dermatology Drugs Market, By Type of Drug, By Animal Type, By Geography

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，獸用皮膚病藥物市場規模將達到 32.8 億美元，到 2033 年將達到 55.7 億美元。預計從 2026 年到 2033 年，該市場將以 7.9% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	32.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.90%	2033年市場規模預測：	55.7億美元

獸用皮膚科藥物是用於治療動物皮膚疾病的藥物。這些藥物旨在治療皮膚癌、細菌感染疾病和寄生蟲感染。獸醫服務的進步使獸醫能夠為各種慢性疾病和感染疾病提供廣泛的治療方案。這些技術使獸醫服務和寵物飼主都能獲得更便利、更經濟的醫療服務。

市場動態

由於寵物飼主對動物健康的日益重視，預計未來獸醫皮膚病市場將顯著成長。此外，寄生蟲生態系統的變化、氣候變遷、病媒與宿主之間相互作用的增加、入侵物種引入地方性流行區以及傳統流行區以外地區病媒傳播感染疾病的高風險，預計也將推動全球獸醫皮膚病市場的成長。分子診斷和治療技術的進步也有望進一步促進獸醫皮膚病市場的成長。

另一方面，嚴格的核准規定和藥物相關的副作用預計將抑制市場成長。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數分析了全球獸醫皮膚病藥物市場的主要參與者：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球獸醫皮膚病藥物市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
透過分析全球獸用皮膚病藥物市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

市場動態
- 促進因素
  - 動物皮膚病發生率增加
  - 寵物主人數量增加
- 抑制因子
  - 開發中國家缺乏意識
  - 藥物的副作用
  - 嚴格的核准規定
- 機會
  - 政府和私部門投資增加
  - 開發最先進治療
影響分析
主要亮點
監管趨勢
產品上市及核准
PEST分析
波特的分析
併購情景

第4章全球獸用皮膚病藥物市場：依藥物類型分類，2021-2033年

抗生素
抗真菌藥物
抗發炎藥
免疫療法藥物
殺蟲劑
其他

第5章全球獸用皮膚病藥物市場：依動物類型分類，2021-2033年

狗
貓
馬
其他

第6章全球獸用皮膚病藥物市場：依地區分類，2021-2033年

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 以色列
- 南非
- 北非
- 中非

第7章競爭情勢

Zoetis Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Virbac
Vetoquinol SA
Dechra Pharmaceuticals PLC
Bayer AG
Ceva Sante Animale
Kindred Biosciences, Inc.
IDEXX Laboratories, Inc.

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI5642

Veterinary Dermatology Drugs Market is estimated to be valued at USD 3.28 Bn in 2026 and is expected to reach USD 5.57 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.28 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.90%	2033 Value Projection:	USD 5.57 Bn

Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.

Market Dynamics

The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.

On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global veterinary dermatology drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market.

Market Segmentation

Global Veterinary Dermatology Drugs Market, By Type of Drug (Revenue, USD Bn, 2021 - 2033)
Antibiotics
Antifungal drugs
Anti-inflammatory drugs
Immunotherapy drugs
Parasiticides
Others
Global Veterinary Dermatology Drugs Market, By Animal Type (Revenue, USD Bn, 2021 - 2033)
Dogs
Cats
Horses
Others
Global Veterinary Dermatology Drugs Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Zoetis Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
Bayer AG
Ceva Sante Animale
Kindred Biosciences, Inc.
IDEXX Laboratories, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type of Drug
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Growing prevalence of skin disease in animals
  - Rise in number of pet owners
- Restraints
  - Lack of awareness across developing countries
  - Side-effects associated with drugs
  - Strict approval regulations
- Opportunities
  - Increasing investment by government and private sectors
  - Development of cutting-edge therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Antifungal drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Anti-inflammatory drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Immunotherapy drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Parasiticides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Veterinary Dermatology Drugs Market , By Animal Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
Horses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)

6. Global Veterinary Dermatology Drugs Market , By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vetoquinol S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dechra Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Kindred Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IDEXX Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views